A detailed history of Factorial Partners, LLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Factorial Partners, LLC holds 339,953 shares of OSUR stock, worth $1.29 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
339,953
Previous 303,627 11.96%
Holding current value
$1.29 Million
Previous $1.29 Million 12.22%
% of portfolio
0.93%
Previous 0.88%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$3.93 - $4.59 $142,761 - $166,736
36,326 Added 11.96%
339,953 $1.45 Million
Q2 2024

Aug 07, 2024

BUY
$4.2 - $6.18 $590,633 - $869,074
140,627 Added 86.27%
303,627 $1.29 Million
Q3 2023

Nov 13, 2023

BUY
$4.4 - $6.91 $66,000 - $103,650
15,000 Added 10.14%
163,000 $966,000
Q2 2023

Aug 02, 2023

SELL
$4.88 - $7.39 $102,480 - $155,190
-21,000 Reduced 12.43%
148,000 $741,000
Q1 2023

May 03, 2023

BUY
$4.66 - $6.52 $83,880 - $117,359
18,000 Added 11.92%
169,000 $1.02 Million
Q4 2022

Feb 13, 2023

SELL
$3.7 - $5.29 $107,300 - $153,410
-29,000 Reduced 16.11%
151,000 $727,000
Q3 2022

Nov 04, 2022

SELL
$2.72 - $4.61 $40,800 - $69,150
-15,000 Reduced 7.69%
180,000 $682,000
Q2 2022

Aug 03, 2022

BUY
$2.71 - $7.12 $265,580 - $697,760
98,000 Added 101.03%
195,000 $528,000
Q1 2022

May 03, 2022

BUY
$6.62 - $9.33 $642,140 - $905,010
97,000 New
97,000 $658,000
Q2 2020

Aug 13, 2020

SELL
$9.71 - $17.87 $582,600 - $1.07 Million
-60,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$5.57 - $10.76 $317,490 - $613,320
57,000 Added 1900.0%
60,000 $646 Million
Q4 2019

Feb 11, 2020

SELL
$7.21 - $8.89 $634,480 - $782,320
-88,000 Reduced 96.7%
3,000 $24.1 Million
Q3 2019

Nov 12, 2019

BUY
$6.57 - $9.46 $597,870 - $860,860
91,000 New
91,000 $680 Million

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $275M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Factorial Partners, LLC Portfolio

Follow Factorial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.